RSV G protein acts as a fractalkine receptor antagonist modulating the immune response to infection, and inhibiting fractalkine-mediated responses including altering pulmonary trafficking of CX3CR1+ immune cells, and modifying the magnitude and cadence of cytokine and chemokine expression [37,38]. This evidence concerns the gene CX3CR1 and infection.